Speaker

January 28, 2022    London, UK

Webinar on

Pharmaceutics and Drug Discovery

Prachi V Atre

Prachi V Atre

USA

Title: Quality risk management in pharmaceutical industry

Abstract:

Recently the application of Quality Risk Management (QRM) in the pharmaceutical industry has evolved and become a mandatory regulatory requirement. QRM is a continuous process of minimizing risks to product quality throughout its life cycle in order to optimize a product’s benefits and outweigh the risks. It is a systematic process for the assessment, control, and review of risks to the quality of the pharmaceutical product. ‘Risk’ is defined as the combination of the probability of occurrence of harm and the severity of that harm. ICH Q9 Guideline, Quality Risk Management illustrates core principles and tools of quality risk management to aid in efficacious and persistent risk-based decisions to both the industries viz. Regulatory and Pharmaceutical in regard to the quality of the drug substance as well as drug product from the patient’s perspective. A few examples of QRM systems that require practical decision-making are Validation, Documentation, Training, Inspection etc. Risk ranking and filtering is one of the widely used basic tools to identify and categorize the potential threat and risk is ranked using risk descriptors such as high, medium or low. Further, a risk score can also be used to define risk descriptors in risk ranking. Usually, an initial risk assessment analysis is conducted followed by final risk assessment analysis to either confirm the low risk or confirm the reduced risk. In conclusion, effective QRM system can facilitate better risk identification and subsequent risk control to improve scientific decisions.

Biography:

Prachi V. Atre has completed her Master’s in Industrial Pharmacy Practice from St.John’s University, Queens, NY, 11439. She has 3+ years of experience in injectables and is currently working as a Formulation Scientist II at Nexus Pharmaceuticals, Inc. She has published poster abstracts and presentations at Annual Meetings and Expositions such as American Asociation of Pharmaceutical Scientists (AAPS) and Controlled Release Society (CRS). She has good written and communication skills and has published review article on injectables recently.